Acasă › Cancer pulmonar cu celule non-pătrate › Arkansas › Springdale
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Springdale, AR
15 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Springdale (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
În curs de recrutareFaza 2/3
- Highlands Oncology Group - Springdale /ID# 277132, Springdale
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 3
- Highlands Oncology Group, PA, Springdale
- Highlands Oncology Group, Springdale
- Highlands Oncology Group, PA, Rogers · La 10 mi distanță
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
În curs de recrutareFaza 3
- Highlands Oncology Group-Research Department ( Site 0062), Springdale
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Highlands Oncology Group, Springdale
- Highlands Oncology Group, Rogers · La 10 mi distanță
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
În curs de recrutareFaza 1/2
- Highlands Oncology Group, PA, Springdale
- Highlands Oncology Group, PA, Rogers · La 10 mi distanță
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Highlands Oncology Group, Springdale
Pan-tumor MRD Study
În curs de recrutareStudiu observațional
- Highlands Oncology Group (HOG), Springdale
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
În curs de recrutareFaza 3
- Research Site, Springdale
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
În curs de recrutareFaza 3
- Local Institution - 0686, Springdale
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 3
- Research Site, Springdale
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
În curs de recrutareFaza 2/3
- Highlands Oncology Group - Springdale, Springdale
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- Highlands Oncology Group, Springdale
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
În curs de recrutareFaza 3
- Highlands Oncology Group, Springdale
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
În curs de recrutareFaza 1
- Highlands Oncology Group, Springdale
- Highlands Oncology Group, Rogers · La 10 mi distanță
BostonGene and Exigent Genomic INsight Study
În curs de recrutareStudiu observațional
- Highlands Oncology Group, Rogers · La 10 mi distanță
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY120 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH56 studii
- Washington, DC55 studii
Alte studii în Springdale
- Schizofrenie7 studii
- Cancer pulmonar6 studii
- Cancer metastatic6 studii
- Cancer de sân5 studii
- Cancer (toate tipurile)5 studii
- Tulburare depresivă majoră5 studii
- Cancer colorectal5 studii
- Depresie4 studii
- Cancer de vezică urinară4 studii
- Carcinom cu celule scuamoase de cap și gât3 studii
- Mielom multiplu3 studii
- Cancer pulmonar cu celule mici3 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.